Phase 3, randomized trial (CheckMate 057) of nivolumab (NIVO) vs. docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC) - subgroup analyses and patient reported outcomes (PROs)

被引：0

作者：

Horn, L. ^{[1
]}

Brahmer, J. ^{[2
]}

Reck, M. ^{[3
]}

Borghaei, H. ^{[4
]}

Spigel, D. ^{[5
]}

Steins, M. ^{[6
]}

Ready, N. ^{[7
]}

Chow, L. ^{[8
]}

Vokes, E. ^{[9
]}

Felip, E. ^{[10
]}

Holgado, E. ^{[11
]}

Barlesi, F. ^{[12
]}

Kohlhaeufl, M. ^{[13
]}

Burgio, M. ^{[14
]}

Fayette, J. ^{[15
]}

Gettinger, S. ^{[16
]}

Harbison, C. ^{[17
]}

Li, A. ^{[17
]}

Finckenstein, F. ^{[17
]}

Paz-Ares, L. ^{[18
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[3] German Ctr Lung Res DZL, ARCN, LungenClin Grosshansclort, Grosshasndorf, Germany

[4] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[5] Sarah Cannon Res Inst, Nashville, TN USA

[6] Thoraxklin Heidelberg gGmbH, Heidelberg, Germany

[7] Duke Univ, Med Ctr, Durham, NC 27706 USA

[8] Univ Washington, Seattle, WA 98195 USA

[9] Univ Chicago, Med & Biol Sci, Chicago, IL 60637 USA

[10] Univ Vall dHebron, Barcelona, Spain

[11] Hosp Madrid, Norte Sanchinarro, Madrid, Spain

[12] Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille, France

[13] Robert Bosch Krankenhaus, Gerlingen, Germany

[14] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy

[15] Ctr Leon Berard, F-69373 Lyon, France

[16] Yale Comprehens Canc Ctr, New Haven, CT USA

[17] Bristol Myers Squibb Co, Princeton, NJ USA

[18] Hosp Univ Virgen Del Rocio, Seville, Spain

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

0352

引用

页码：27 / 27

页数：1